Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Network Comparison Type Value Type Interaction Map Filtered red network_comparison green
Results: HTML CSV LaTeX Showing element 530 to 579 of 33156 in total
Network Comparison Type: Divided
Filtered: 1
\def\wcA{0.11111111111111\textwidth} \def\wcB{0.11111111111111\textwidth} \def\wcC{0.11111111111111\textwidth} \def\wcD{0.11111111111111\textwidth} \def\wcE{0.11111111111111\textwidth} \def\wcF{0.11111111111111\textwidth} \def\wcG{0.11111111111111\textwidth} \def\wcH{0.11111111111111\textwidth} \begin{longtable}{|c|c|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Value Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent green\vspace{3pt}}\\ \hline \hline \multirow{7}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent GNAT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.14\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25805\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.075\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MAGEA8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MYO15A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 63.8686\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.35128\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 47.2654\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent NFU1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 12176.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.1318\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 13781.8\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent SEPT6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 74378.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25751\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 93531.9\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent T\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent brachyury protein (t protein). [source:swissprot;acc:o15178]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 61.687\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10559\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 68.2003\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent UBR4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 165.535\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10505\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 149.799\vspace{3pt}}\\\cline{1-3}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 239.692\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10455\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 217.005\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent ARRB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 6475.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.59177\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 10307.5\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent GNAZ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 267.139\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25805\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.075\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MAGEC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent PYGM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 63.8686\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.35128\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 47.2654\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent RASAL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 55.9786\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10514\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 61.8641\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent UBAC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 19498.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12932\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 17265.4\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent UBR4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 27909.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25653\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 35068.7\vspace{3pt}}\\\cline{1-3}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ALDH4A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor (ec 1.5.1.12) (p5c dehydrogenase). [source:swissprot;acc:p30038]\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 80538.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25465\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 64191.7\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent APBA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent amyloid beta a4 precursor protein-binding family a member 1 (neuron- specific x11 protein) (neuronal munc18-1-interacting protein 1) (mint-1) (adapter protein x11alpha). [source:swissprot;acc:q02410]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 60.7884\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10405\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 67.1136\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent GNAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.14\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25805\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.075\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MAGEA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent NEUROD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 27.9136\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33581\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 37.2872\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent SLC7A13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent amino acid transporter xat2; likely ortholog of mouse aspartate/glutamate transporter 1 (agt1). [source:refseq;acc:nm\_138817]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 6991.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7848.45\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent SPATA6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 6475.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.59177\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 10307.5\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent TEX28P2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent testis-specific protein tex28. [source:swissprot;acc:o15482]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 259.517\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10425\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 235.017\vspace{3pt}}\\\hline \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 70\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent AMPD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6475.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.59177\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 10307.5\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent CHD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 27.9136\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33581\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 37.2872\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent GNAI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 267.142\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25804\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.074\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent GOSR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 27 kda golgi snare protein (golgi snap receptor complex member 2) (membrin). [source:swissprot;acc:o14653]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 259.517\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10425\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 235.017\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent PLAA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent phospholipase a-2-activating protein (plap) (pla2p). [source:swissprot;acc:q9y263]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 80538.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25465\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 64191.7\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent SLC7A7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent y+l amino acid transporter 1 (y(+)l-type amino acid transporter 1) (y+lat-1) (y+lat1) (monocyte amino acid permease 2) (mop-2). [source:swissprot;acc:q9um01]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6991.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7848.45\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent TFDP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent transcription factor dp-2 (e2f dimerization partner 2). [source:swissprot;acc:q14188]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 61.9982\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10058\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 68.2337\vspace{3pt}}\\\cline{1-4}\cline{6-8} \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 71\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent cysteine-rich protein 1 (cysteine-rich intestinal protein) (crip) (cysteine-rich heart protein) (hcrhp). [source:swissprot;acc:p50238]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 230.944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10421\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 209.149\vspace{3pt}}\\\cline{3-8} &&\parbox{\wcC}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4556.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.54716\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2945.26\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent ARAF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 63411.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.24169\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 51068.8\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent CDK2AP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 27.9136\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33581\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 37.2872\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent GNAI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 267.144\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25802\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.073\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MAGEA10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent SLC7A11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cystine/glutamate transporter (amino acid transport system xc-) (xct) (calcium channel blocker resistance protein ccbr1). [source:swissprot;acc:q9upy5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 6991.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7848.45\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent TAF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tbp-associated factor 2; taf2 rna polymerase ii, tata box binding protein (tbp)-associated factor, 150 kd; tata box binding protein (tbp)-associated factor, rna polymerase ii, b, 150kd; cofactor of initiator function, 150kd subunit. [source:refseq;acc:nm\_003184]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 59.6397\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10048\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 65.6325\vspace{3pt}}\\\hline \multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent GNAI3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.144\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25802\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.073\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent MAGEB4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 219048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.68808\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 129762\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent MTUS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent mitochondrial tumor suppressor gene 1; transcription factor mtsg1; at2 receptor-interacting protein 1; erythroid differentiation-related gene. [source:refseq;acc:nm\_020749]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Rooted\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 63.1259\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.09987\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 69.4305\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent NEUROD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 27.9136\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33581\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 37.2872\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent PPP2R2D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 4556.79\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.54715\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 2945.28\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent RAF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 63404.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.24163\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 51065.9\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent SLC7A6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent solute carrier family 7 (cationic amino acid transporter, y+ system), member 6. [source:refseq;acc:nm\_003983]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6991.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7848.45\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent SMYD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent set and mynd domain containing 2; hskm-b protein; zinc finger, mynd domain containing 14. [source:refseq;acc:nm\_020197]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 230.944\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.10421\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 209.149\vspace{3pt}}\\\cline{1-4}\cline{6-8} \multirow{3}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent CPN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent carboxypeptidase n 83 kda chain (carboxypeptidase n regulatory subunit) (fragment). [source:swissprot;acc:p22792]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 63279.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.24046\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 51013.1\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent EIF4B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent eukaryotic translation initiation factor 4b (eif-4b). [source:swissprot;acc:p23588]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 6991.78\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.12253\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7848.45\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent JPH3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 288\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.25694\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 362\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Hugo is the HGNC identifier if it exists
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/